{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:05:16Z","timestamp":1784135116008,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200644"],"award-info":[{"award-number":["82200644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371756"],"award-info":[{"award-number":["82371756"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science Fund of Universities of Anhui Province for Distinguished Young Scholars","award":["2023AH020032"],"award-info":[{"award-number":["2023AH020032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02328-0","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:23:31Z","timestamp":1784132611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Niflumic acid suppresses NLRP3 inflammasome activation by limiting chloride efflux and mitochondrial ROS production"],"prefix":"10.1007","volume":"75","author":[{"given":"Yuanhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghua","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7212-7156","authenticated-orcid":false,"given":"Xuefu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2328_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"key":"2328_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, Nunez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41:1012\u201321.","journal-title":"Trends Biochem Sci"},{"key":"2328_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"2328_CR4","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18:2114\u201327.","journal-title":"Cell Mol Immunol"},{"key":"2328_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:588\u2013606.","journal-title":"Nat Rev Drug Discov"},{"key":"2328_CR6","doi-asserted-by":"publisher","first-page":"1019365","DOI":"10.3389\/fimmu.2022.1019365","volume":"13","author":"T Sun","year":"2022","unstructured":"Sun T, Xie R, He H, Xie Q, Zhao X, Kang G, et al. Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization via GPR35. Front Immunol. 2022;13:1019365.","journal-title":"Front Immunol"},{"key":"2328_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","volume":"23","author":"L Vande Walle","year":"2024","unstructured":"Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov. 2024;23:43\u201366.","journal-title":"Nat Rev Drug Discov"},{"key":"2328_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3109\/03009747309095202","volume":"1","author":"OA Sydnes","year":"1973","unstructured":"Sydnes OA. A clinical investigation of niflumic acid in the treatment of rheumatoid arthritis. Scand J Rheumatol Suppl. 1973;1:8\u201311.","journal-title":"Scand J Rheumatol Suppl"},{"key":"2328_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0026-895X(25)10907-3","volume":"37","author":"MM White","year":"1990","unstructured":"White MM, Aylwin M. Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes. Mol Pharmacol. 1990;37:720\u20134.","journal-title":"Mol Pharmacol"},{"key":"2328_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.bjp.0706954","volume":"150","author":"A Liantonio","year":"2007","unstructured":"Liantonio A, Giannuzzi V, Picollo A, Babini E, Pusch M, Conte Camerino D. Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium. Br J Pharmacol. 2007;150:235\u201347.","journal-title":"Br J Pharmacol"},{"key":"2328_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.chembiol.2017.02.003","volume":"24","author":"CE Smith","year":"2017","unstructured":"Smith CE, Soti S, Jones TA, Nakagawa A, Xue D, Yin H. Non-steroidal anti-inflammatory drugs are caspase inhibitors. Cell Chem Biol. 2017;24:281\u201392.","journal-title":"Cell Chem Biol"},{"key":"2328_CR12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.immuni.2022.04.015","volume":"55","author":"A Eisenstein","year":"2022","unstructured":"Eisenstein A, Hilliard BK, Pope SD, Zhang C, Taskar P, Waizman DA, et al. Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs. Immunity. 2022;55:1082\u201395. e5.","journal-title":"Immunity"},{"key":"2328_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237\u201341.","journal-title":"Nature"},{"key":"2328_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature04515","volume":"440","author":"S Mariathasan","year":"2006","unstructured":"Mariathasan S, Weiss DS, Newton K, McBride J, O\u2019Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006;440:228\u201332.","journal-title":"Nature"},{"key":"2328_CR15","doi-asserted-by":"publisher","first-page":"C748","DOI":"10.1152\/ajpcell.00228.2012","volume":"304","author":"T Shimizu","year":"2013","unstructured":"Shimizu T, Iehara T, Sato K, Fujii T, Sakai H, Okada Y. TMEM16F is a component of a Ca2+-activated Cl- channel but not a volume-sensitive outwardly rectifying Cl- channel. Am J Physiol Cell Physiol. 2013;304:C748\u201359.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2328_CR16","first-page":"1","volume":"51","author":"B Lee","year":"2019","unstructured":"Lee B, Hong GS, Lee SH, Kim H, Kim A, Hwang EM, et al. Anoctamin 1\/TMEM16A controls intestinal Cl(-) secretion induced by carbachol and cholera toxin. Exp Mol Med. 2019;51:1\u201314.","journal-title":"Exp Mol Med"},{"key":"2328_CR17","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.1016\/S0140-6736(17)31744-0","volume":"390","author":"BR da Costa","year":"2017","unstructured":"da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, J\u00fcni P, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017;390:E21\u201333.","journal-title":"Lancet"},{"key":"2328_CR18","doi-asserted-by":"publisher","first-page":"12504","DOI":"10.1038\/ncomms12504","volume":"7","author":"MJ Daniels","year":"2016","unstructured":"Daniels MJ, Rivers-Auty J, Schilling T, Spencer NG, Watremez W, Fasolino V, et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models. Nat Commun. 2016;7:12504.","journal-title":"Nat Commun"},{"key":"2328_CR19","doi-asserted-by":"publisher","first-page":"E9371","DOI":"10.1073\/pnas.1812744115","volume":"115","author":"JP Green","year":"2018","unstructured":"Green JP, Yu S, Martin-Sanchez F, Pelegrin P, Lopez-Castejon G, Lawrence CB, et al. Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming. Proc Natl Acad Sci U S A. 2018;115:E9371\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2328_CR20","doi-asserted-by":"publisher","first-page":"107016","DOI":"10.1016\/j.phrs.2023.107016","volume":"198","author":"X Wu","year":"2023","unstructured":"Wu X, Yi X, Zhao B, Zhi Y, Xu Z, Cao Y, et al. The volume regulated anion channel VRAC regulates NLRP3 inflammasome by modulating itaconate efflux and mitochondria function. Pharmacol Res. 2023;198:107016.","journal-title":"Pharmacol Res"},{"key":"2328_CR21","doi-asserted-by":"crossref","unstructured":"Green JP, Swanton T, Morris LV, El-Sharkawy LY, Cook J, Yu S et al. LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation. Elife 2020;9:e59704.","DOI":"10.7554\/eLife.59704"},{"key":"2328_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s13577-020-00482-z","volume":"34","author":"G Yang","year":"2021","unstructured":"Yang G, Tang X, Tan L, Nong D, Yang P, Ning H. Upregulation of miR-144-3p protects myocardial function from ischemia-reperfusion injury through inhibition of TMEM16A Ca(2+)-activated chloride channel. Hum Cell. 2021;34:360\u201371.","journal-title":"Hum Cell"},{"key":"2328_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.4103\/1673-5374.350211","volume":"18","author":"ZQ Cui","year":"2023","unstructured":"Cui ZQ, Hu XY, Yang T, Guan JW, Gu Y, Li HY, et al. TMEM16F may be a new therapeutic target for Alzheimer\u2019s disease. Neural Regen Res. 2023;18:643\u201351.","journal-title":"Neural Regen Res"},{"key":"2328_CR24","doi-asserted-by":"crossref","unstructured":"Ousingsawat J, Wanitchakool P, Kmit A, Romao AM, Jantarajit W, Schreiber R et al. Anoctamin 6 mediates effects essential for innate immunity downstream of P2X receptors in macrophages. Nat Commun 2015;6:6245.","DOI":"10.1038\/ncomms7245"},{"key":"2328_CR25","doi-asserted-by":"publisher","first-page":"10555","DOI":"10.1038\/ncomms10555","volume":"7","author":"M Karmakar","year":"2016","unstructured":"Karmakar M, Katsnelson MA, Dubyak GR, Pearlman E. Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1beta secretion in response to ATP. Nat Commun. 2016;7:10555.","journal-title":"Nat Commun"},{"key":"2328_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41419-018-0373-8","volume":"9","author":"J Ousingsawat","year":"2018","unstructured":"Ousingsawat J, Wanitchakool P, Schreiber R, Kunzelmann K. Contribution of TMEM16F to pyroptotic cell death. Cell Death Dis. 2018;9:300.","journal-title":"Cell Death Dis"},{"key":"2328_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.celrep.2019.12.066","volume":"30","author":"N Wu","year":"2020","unstructured":"Wu N, Cernysiov V, Davidson D, Song H, Tang J, Luo S, et al. Critical role of lipid scramblase TMEM16F in phosphatidylserine exposure and repair of plasma membrane after pore formation. Cell Rep. 2020;30:1129\u2013e11405.","journal-title":"Cell Rep"},{"key":"2328_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1152\/physrev.00039.2011","volume":"94","author":"N Pedemonte","year":"2014","unstructured":"Pedemonte N, Galietta LJ. Structure and function of TMEM16 proteins (anoctamins). Physiol Rev. 2014;94:419\u201359.","journal-title":"Physiol Rev"},{"key":"2328_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41467-023-44377-7","volume":"15","author":"Z Ye","year":"2024","unstructured":"Ye Z, Galvanetto N, Puppulin L, Pifferi S, Flechsig H, Arndt M, et al. Structural heterogeneity of the ion and lipid channel TMEM16F. Nat Commun. 2024;15:110.","journal-title":"Nat Commun"},{"key":"2328_CR30","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1038\/s41467-023-40410-x","volume":"14","author":"S Feng","year":"2023","unstructured":"Feng S, Puchades C, Ko J, Wu H, Chen Y, Figueroa EE, et al. Identification of a drug binding pocket in TMEM16F calcium-activated ion channel and lipid scramblase. Nat Commun. 2023;14:4874.","journal-title":"Nat Commun"},{"key":"2328_CR31","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1038\/s41467-019-09778-7","volume":"10","author":"T Le","year":"2019","unstructured":"Le T, Jia Z, Le SC, Zhang Y, Chen J, Yang H. An inner activation gate controls TMEM16F phospholipid scrambling. Nat Commun. 2019;10:1846.","journal-title":"Nat Commun"},{"key":"2328_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41423-019-0201-9","volume":"17","author":"X Dong","year":"2020","unstructured":"Dong X, Zheng Z, Lin P, Fu X, Li F, Jiang J, et al. ACPAs promote IL-1beta production in rheumatoid arthritis by activating the NLRP3 inflammasome. Cell Mol Immunol. 2020;17:261\u201371.","journal-title":"Cell Mol Immunol"},{"key":"2328_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10753-023-01795-5","volume":"46","author":"J Gao","year":"2023","unstructured":"Gao J, Zhang H, Yang Y, Tao J. Therapeutic potential of targeting the NLRP3 inflammasome in rheumatoid arthritis. Inflammation. 2023;46:835\u201352.","journal-title":"Inflammation"},{"key":"2328_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02328-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:23:34Z","timestamp":1784132614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02328-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2328"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02328-0","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"178"}}